| Title |
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems
|
|---|---|
| Published in |
JAMA: Journal of the American Medical Association, June 2015
|
| DOI | 10.1001/jama.2015.6199 |
| Pubmed ID | |
| Authors |
Kevin P. Hill |
| Abstract |
As of March 2015, 23 states and the District of Columbia had medical marijuana laws in place. Physicians should know both the scientific rationale and the practical implications for medical marijuana laws. To review the pharmacology, indications, and laws related to medical marijuana use. The medical literature on medical marijuana was reviewed from 1948 to March 2015 via MEDLINE with an emphasis on 28 randomized clinical trials of cannabinoids as pharmacotherapy for indications other than those for which there are 2 US Food and Drug Administration-approved cannabinoids (dronabinol and nabilone), which include nausea and vomiting associated with chemotherapy and appetite stimulation in wasting illnesses. Use of marijuana for chronic pain, neuropathic pain, and spasticity due to multiple sclerosis is supported by high-quality evidence. Six trials that included 325 patients examined chronic pain, 6 trials that included 396 patients investigated neuropathic pain, and 12 trials that included 1600 patients focused on multiple sclerosis. Several of these trials had positive results, suggesting that marijuana or cannabinoids may be efficacious for these indications. Medical marijuana is used to treat a host of indications, a few of which have evidence to support treatment with marijuana and many that do not. Physicians should educate patients about medical marijuana to ensure that it is used appropriately and that patients will benefit from its use. |
Twitter Demographics
The data shown below were collected from the profiles of 601 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 273 | 45% |
| Canada | 38 | 6% |
| United Kingdom | 13 | 2% |
| Chile | 9 | 1% |
| Australia | 8 | 1% |
| Mexico | 6 | <1% |
| Spain | 6 | <1% |
| Italy | 4 | <1% |
| Colombia | 3 | <1% |
| Other | 43 | 7% |
| Unknown | 198 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 411 | 68% |
| Practitioners (doctors, other healthcare professionals) | 147 | 24% |
| Scientists | 24 | 4% |
| Science communicators (journalists, bloggers, editors) | 16 | 3% |
| Unknown | 3 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 957 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | <1% |
| Colombia | 1 | <1% |
| Australia | 1 | <1% |
| Chile | 1 | <1% |
| Spain | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 946 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 160 | 17% |
| Researcher | 109 | 11% |
| Student > Master | 104 | 11% |
| Other | 100 | 10% |
| Student > Ph. D. Student | 78 | 8% |
| Other | 235 | 25% |
| Unknown | 171 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 278 | 29% |
| Psychology | 77 | 8% |
| Agricultural and Biological Sciences | 60 | 6% |
| Nursing and Health Professions | 54 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 52 | 5% |
| Other | 224 | 23% |
| Unknown | 212 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 887. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2023.
All research outputs
#18,525
of 24,503,376 outputs
Outputs from JAMA: Journal of the American Medical Association
#471
of 34,547 outputs
Outputs of similar age
#128
of 268,657 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#5
of 438 outputs
Altmetric has tracked 24,503,376 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 34,547 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 74.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,657 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 438 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.